Goldsmith Bruce A 4
4 · ALLOS THERAPEUTICS INC · Filed Nov 17, 2011
Insider Transaction Report
Form 4
Goldsmith Bruce A
VP, Corporate Development
Transactions
- Sale
Common Stock
2011-11-16$1.43/sh−300$430→ 179,259 total - Sale
Common Stock
2011-11-15$1.44/sh−12,465$18,008→ 179,559 total
Footnotes (3)
- [F1]These shares are being sold pursuant to a 10b5-1 plan for Bruce A. Goldsmith in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on October 20, 2011. The delivery of shares was delayed until November 14, 2011, due to legal / regulatory restrictions applicable to the Company.
- [F2]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $1.43 to $1.47. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F3]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $1.43 to $1.4325. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.